Marguerite Marschner, PA
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 45.0% of the total.
Across 218 payments — averaging $13.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$371
- Takeda Pharmaceuticals U.S.A., Inc.$319
- Sanofi$219
- Pfizer$158
- Regeneron Healthcare Solutions, Inc.$105
- plus $487 from 14 others
What the payments were for
- Food & beverage$2,98499%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 122 | $1,357 |
| Johnson & Johnson | 26 | $371 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $319 |
| Sanofi | 11 | $219 |
| Pfizer | 9 | $158 |
| Regeneron Healthcare Solutions, Inc. | 6 | $105 |
| Bristol Myers Squibb | 6 | $94 |
| Ardelyx, Inc. | 3 | $56 |
| Celltrion USA Inc. | 2 | $49 |
| QOL Medical, LLC | 2 | $42 |
| Gilead | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $30 |
| AMAG Pharmaceuticals, Inc. | 1 | $28 |
| Pharming Healthcare, Inc. | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Redhill Biopharma Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$3,015 in reported general payments places this provider in the 75th percentile of 263 medical providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 59 | $51,813 |
| TrulancePlecanatide | 12 | $7,600 |
| Alosetron Hcl | 22 | $7,580 |
| VoqueznaVonoprazan Fumarate | 11 | $7,138 |
| Dexlansoprazole DrDexlansoprazole | 22 | $7,016 |
| DexilantDexlansoprazole | 11 | $6,827 |
| MovantikNaloxegol Oxalate | 14 | $5,720 |
| Mesalamine | 14 | $5,099 |
| Omeprazole | 225 | $4,875 |
| Sucralfate | 44 | $3,871 |
| Mesalamine ErMesalamine | 12 | $3,186 |
| Budesonide DrBudesonide | 38 | $3,153 |
| Pantoprazole Sodium | 170 | $2,182 |
| CholestyramineCholestyramine (With Sugar) | 34 | $1,493 |
| Cholestyramine LightCholestyramine | 12 | $1,373 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,357 | $51,81359 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $35 | $7,60012 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Dexilant | $319 | $6,82711 claims |
| Redhill Biopharma Inc.Movantik | $17 | $5,72014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 263 medical providers in Utah.
Other medical in Sandy
- Elisa WilcoxSalt Lake City$178K
- Val WarnerLayton$51K
- Viet leSalt Lake City$42K
- Carmelo DiazSalt Lake City$35K
- Shari CombeSalt Lake City$22K
- Kelly MikesellOgden$19K
- Jennifer CoombsSlc$12K
- Brandon HansenRiverton$10K
- Daniel CorryCedar City$10K
- Mark UdySt George$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.